Cardiovalve Submits CE Approval Dossier Following TARGET Trial Success Cardiovalve has submitted a CE technical dossier for its transcatheter tricuspid valve replacement system, following promising TARGET study results.

Cardiovalve Submits CE Approval Dossier Following TARGET Trial Success #China #Hangzhou #Venus_Medtech #Cardiovalve #TARGET_Study

Cardiovalve Achieves Key CE Submission After Successful TARGET Study Results Cardiovalve has submitted its CE technical file for the transcatheter tricuspid valve replacement device, achieving a significant milestone post-TARGET study.

Cardiovalve Achieves Key CE Submission After Successful TARGET Study Results #None #Venus_Medtech #Cardiovalve #TARGET_Study

Cardiovalve Advances in Heart Valve Technology with CE Submission After TARGET Study Success Cardiovalve has submitted its CE technical file for a new valve system after successful TARGET study results, marking a significant step in heart treatment technology.

Cardiovalve Advances in Heart Valve Technology with CE Submission After TARGET Study Success #China #Hangzhou #Venus_Medtech #Cardiovalve #TARGET_Study